Edition:
India

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

70.00EUR
3:41pm IST
Change (% chg)

€-0.30 (-0.43%)
Prev Close
€70.30
Open
€70.30
Day's High
€70.50
Day's Low
€70.00
Volume
9,125
Avg. Vol
154,301
52-wk High
€79.80
52-wk Low
€45.00

Chart for

About

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial... (more)

Overall

Beta: 0.36
Market Cap(Mil.): €8,348.02
Shares Outstanding(Mil.): 118.36
Dividend: 0.33
Yield (%): 0.47

Financials

BRIEF-Biomerieux FY ‍Sales Rise 10.2 Pct To EUR 2,288 Million

* ‍SALES MOMENTUM IN 2017 WITH 10.2% GROWTH IN SALES TO EUR 2,288 MILLION IN SALES​

23 Jan 2018

BRIEF-Biomerieux Appoints Alexandre Merieux As CEO And Chairman

* ALEXANDRE MÉRIEUX APPOINTED CHAIRMAN AND CEO OF BIOMÉRIEUX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

15 Dec 2017

BRIEF-Veneto Banca seals deal with Attestor over BIM stake sale

* signed an agreement with Trinity Investments Designated Activity Company, an investment company managed by Attestor Capital, over sale of its stake in BIM

25 Oct 2017

BRIEF-Biomerieux Q3 sales up at ‍​1.67 billion euros

* Q3 SALES EUR ‍​1.67 BILLION VERSUS EUR 1.51 BILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

18 Oct 2017

European stocks bounce back as strong earnings in focus

LONDON Investors piled back into European stocks on Wednesday, boosting indexes higher in a rally a day after geopolitical concern caused a drop across equity markets.

30 Aug 2017

UPDATE 2-European stocks bounce back as strong earnings in focus

* Second quarter earnings to grow 16 pct - TR (Adds closing prices)

30 Aug 2017

European stocks bounce back as strong earnings in focus

LONDON, Aug 30 Investors piled back into European stocks on Wednesday, boosting indexes higher in a relief rally after geopolitical concerns caused a sharp dip across equity markets.

30 Aug 2017

BRIEF-Biomerieux H1 operating income rises to 163 million euros

* IS NOW TARGETING ORGANIC SALES GROWTH FOR FULL YEAR OF BETWEEN 9 PCT AND 10 PCT

30 Aug 2017

Earnings vs. Estimates